Women's supplements brand O Positiv explores sale, sources say
NEW YORK, June 11 (Reuters) - O Positiv Health is exploring a sale that could value the women's health supplements company at around $1 billion, according to three people familiar with the matter.
The founder-owned business is working with investment bank Jefferies on the sale effort, said the sources, who added that O Positiv is projecting $275 million of revenue this year after generating around $225 million in 2024.
The sources cautioned that no deal was guaranteed, and spoke on condition of anonymity to discuss private information.
Jefferies declined to comment. O Positiv did not respond to a comment request.
Siblings Bobby and Brianna Bitton launched O Positiv in 2018. The company makes vitamins and probiotics that address a variety of health concerns, from PMS and menopause symptoms to vaginal and gut health.
The products are sold on the company's website, as well as through retailers including Walmart (WMT.N), opens new tab, Target (TGT.N), opens new tab and Amazon (AMZN.O), opens new tab.
Consumer health companies and private equity firms alike have put more emphasis on investing in the women's health space in recent years, which has created a significant pool of buyers for brands founded by entrepreneurs.
Such deals include Pharmavite buying Bonafide in November 2023 and L Catterton, in partnership with actress Naomi Watts, acquiring Stripes Beauty last year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
34 minutes ago
- Daily Mail
Starbucks' makes shock U-turn after years of job cuts and plunging sales
Starbucks has launched its biggest hiring spree in history — aimed at finally tackling the number one gripe from frustrated customers. The recruitment blitz— adding as many as 85,000 workers across its 17,000 US locations — is a bold move aimed at slashing long wait times. Customers have grown weary of waiting 20 minutes for a drink, with many walking away from the chain entirely. Soaring prices and what critics call a 'soulless' in-store experience have only added to the exodus — helping drive a sharp drop in sales. New CEO Brian Niccol, speaking to 14,000 store managers at a Las Vegas event on Wednesday, called it 'the biggest human capital investment in connection in the history of Starbucks.' He said the goal isn't just to speed up service, but to ease pressure on overworked employees and bring back the warmth and personal touch that once made Starbucks a beloved 'third place' between home and work. 'Your rosters are going to expand with this,' Niccol told managers, who can begin hiring from August. Five years ago, Starbucks stores averaged 23 employees. Cost-cutting has since trimmed that number down to 18 to 19 — four to five fewer workers per location. Restoring pre-Covid staffing levels would mean hiring between 68,000 and 85,000 people across all US stores. Even focusing solely on the 11,000 company-owned locations, the increase would still be a massive 44,000 to 55,000 hires. Jodi Love, a portfolio manager at T Rowe Price, a Starbucks shareholder, estimated the labor investments would add more than $1bn in additional spending to fiscal 2026. But the move is expected to resonate with baristas on the frontlines, many of whom have long complained of chronic understaffing that fuels delays and drains morale. The new hires are also expected to support Starbucks' efforts to bring back a more personal touch — including a new policy asking baristas to handwrite notes on customers' cups. Explaining the U-turn, Niccol told the Financial Times: 'We over-rotated on the idea of equipment and that replacing the humanity of service,' Niccol told the Financial Times. 'And I think service is our point of difference. Despite everybody saying they're more connected than ever, everything I read is people feel more lonely than ever. 'I think part of the problem is there aren't enough third places anymore.' The new Starbucks boss has said he will simplify the chain's 'overly complex menu' in a bid to win back customers amid slumping sales Customers have increasingly been turned off by long wait times and rising prices at the chain Starbucks is scaling back the promotions and discounts offered through its mobile app Starbucks held Niccol was hired last year in an effort to turn around the struggling chain. Former CEO Howard Shultz agreed with Niccol telling Wednesday's company event 'we're not a company based on technology. 'That enables us, we're a company based on people.' The former Chipotle boss has embarked on a series of plans to return Starbucks to its original 'third place between home and work' concept. Coffee drinkers have turned away from the chain in recent years, put off by high beverage prices, long wait times and impersonal experiences. Niccol has set about axing complicated drinks from Starbucks menus, asking staff to put messages on customer's coffee cups and scaling back promotions. The plan will help address the major customer pet peeve of long wait times before getting their hands on a coffee. It will also likely be popular with front of house employees who have complained of chronic issues with understaffing, which compounds the backlogs.
Daily Mail
38 minutes ago
- Daily Mail
After closed-door 'shouting match' with Trump aide, key GOP senator clears the air on THIS issue
Senator Ron Johnson set the record straight after allegations of a 'shouting match' between him and a top Trump aide emerged from a Thursday afternoon meeting. The Wisconsin Republican reportedly was involved in a 'shouting match' with President Donald Trump 's White House Deputy Chief of Staff Stephen Miller over the border security funding number contained in the 'big,beautiful' GOP spending bill currently being worked on in the Senate. Johnson, a fiscal conservative who has voiced his concerns about the bill's impact on the towering national debt, is a critical vote that the White House wants to secure. Johnson cleared the air to the Daily Mail via a statement from his press office Thursday. He did not deny that the spat took place, but any hatchet that came out behind closed doors seemed to have been buried. 'Stephen didn't realize that we didn't have the detailed breakdown in cost, so he explained why the wall was going to be more expensive. Simple misunderstanding, quickly resolved,' Johnson noted. 'We are all huge supporters of Stephen and providing the administration the funding they need to clean up the enormous mess created by Biden and the Democrats,' Johnson added. The impetus of the reported 'shouting match' was when Johnson said Miller's border security numbers didn't add up. After the closed door meeting, Johnson told reporters that Miller's justification for additional border funding was enough to convince him, adding 'if anything, we maybe ought to need more' funding. In a May explainer published to his website titled 'The Ugly Truth About the 'Big Beautiful Bill'', Johnson outlined his opposition to the budget bill, primarily on the basis of the sheer cost of the proposed package. The explainer was published on May 12th, before the House of Representatives passed their version of the spending bill just before the Memorial Day recess. 'There's nothing now to justify this abnormal level of government spending. Pathetically, Congress is having a hard time agreeing on a reduction of even $1.5 trillion from that 10-year amount,' Johnson noted at the time. The Wisconsin senator isn't the only one opposed to the eye-popping cost of the House spending package. Kentucky Senator Rand Paul has shared opposition to the legislation as well, due to the projected new additions to the national debt. While he wants to see the President's 2017 tax cuts extended, Paul has portrayed the current $5 trillion in new debt as 'Biden spending levels.'
Reuters
an hour ago
- Reuters
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
June 12 (Reuters) - Thermo Fisher Scientific (TMO.N), opens new tab plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familiar with the matter. The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business, including its microbiology unit, which produces infectious disease testing equipment, according to the Financial Times. The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset. Thermo Fisher did not immediately respond to a Reuters' request for comment. In February, the company acquired Solventum's purification and filtration business for about $4.1 billion in cash.
